Loading...
•
Jun 30, 2025
Healthpeak Q2 2025 Earnings Report
Healthpeak reported Q2 2025 results with modest earnings growth and strong leasing activity.
Key Takeaways
Healthpeak delivered solid Q2 2025 results with steady revenue and leasing momentum, despite lower net income year-over-year. The company expanded outpatient developments and maintained healthy liquidity.
Net income reached $31.6M with diluted EPS of $0.05
Total revenue was $694.3M, slightly down from last year
1.5M sq. ft. of new and renewal leases signed in Q2
Entered two new outpatient development agreements worth $148M
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Healthpeak reaffirmed full-year 2025 guidance with stable NOI growth and slightly lower EPS expectations.
Positive Outlook
- Reaffirmed FFO as Adjusted guidance of $1.81 – $1.87 per share
- Projected Same-Store Cash NOI growth of 3.0% – 4.0%
- Strong liquidity of $2.3B available
- Outpatient developments expected to yield mid-7% cash returns
- Continued leasing momentum with high retention rates
Challenges Ahead
- Lowered diluted earnings per share range to $0.25 – $0.31
- Diluted Nareit FFO guidance revised slightly downward
- Net income declined YoY due to lower property sales gains
- Increased operating and merger-related costs
- Interest expenses remain elevated
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...